A rare case of velopharyngeal insufficiency in a patient with Behçet’s disease  by Kaya, Kamil Hakan et al.
Egyptian Journal of Ear, Nose, Throat and Allied Sciences (2015) 16, 167–169HO ST E D  BY
Egyptian Society of Ear, Nose, Throat and Allied Sciences
Egyptian Journal of Ear, Nose, Throat and Allied
Sciences
www.ejentas.comCASE REPORTA rare case of velopharyngeal insuﬃciency
in a patient with Behc¸et’s disease* Corresponding author at: Bakırko¨y Dr. Sadi Konuk Eg˘itim ve
Arastırma Hastanesi, Zuhuratbaba Mah. Tevﬁk Sag˘lam Cad. No:11,
Bakırko¨y, Istanbul, Turkey. Tel.: +90 5335976636.
E-mail address: dr.mcelik@yahoo.com (M. C¸elik).
Peer review under responsibility of Egyptian Society of Ear, Nose,
Throat and Allied Sciences.
http://dx.doi.org/10.1016/j.ejenta.2015.06.001
2090-0740 ª 2015 Egyptian Society of Ear, Nose, Throat and Allied Sciences. Production and hosting by Elsevier B.V. All rights reservKamil Hakan Kaya a, Yakup Yegin a, Mustafa C¸elik a,*, Murat Yılmaz b,
Zahide Mine Yazıcı a, Fatma Tu¨lin Kayhan aa Bakırko¨y Dr. Sadi Konuk Training and Research Hospital, Department of Otorhinolaryngology – Head and Neck Surgery,
Istanbul, Turkey





OtolaryngologyAbstract Velopharyngeal insufﬁciency (VPI), in which the velopharyngeal port does not close
during speech, is an important condition that reduces the quality of life in affected patients.
Behc¸et’s disease (BD) is a systemic autoimmune vasculitis with effects on many organs and systems
in the body. Patients with BD may have otorhinolaryngological symptoms as part of its
multi-system disease involvement. In rare cases, autoimmune diseases have been linked to VPI.
Here we report the ﬁrst case of BD diagnosed in a patient with VPI.
ª 2015 Egyptian Society of Ear, Nose, Throat and Allied Sciences. Production and hosting by Elsevier
B.V. All rights reserved.1. Introduction
In velopharyngeal insufﬁciency (VPI), the velopharyngeal port
(VP) does not close during speech. The most common cause of
VPI is secondary cleft palate. Other causes include submucous
cleft palate, neuromuscular abnormalities, adenoidectomy, tis-
sue defects, pharyngomegaly, and idiopathic congenital
velopharyngeal insufﬁciencies. In rare cases, autoimmune dis-
eases have been linked to VPI. Here we report the ﬁrst case
of VPI in a patient diagnosed with Behc¸et’s disease (BD).2. Case report
A 25-year-old male presented with hypernasal speech, nasal
regurgitation of ﬂuids, and dysphagia for the past 4 years.
His history included oral aphthous lesions, two incidences of
genital ulcers, skin rashes, and hospitalization in the intensive
care unit with orotracheal intubation for 20 days because of
severe upper respiratory infection and laryngeal edema. His
parents are second-degree relatives. The VP did not close dur-
ing speech by using ﬂexible endoscopy and ﬂexible endoscopic
evaluation revealed the presence of VPI. Oropharyngeal exam-
ination revealed the presence of a highly ﬁbrotic right palatine
tonsil, an almost nonexistent uvula, ulcers on the same side of
the dorsal aspect of the tongue, and scarring of the soft palate
(Fig. 1). The lingual ulcers were biopsied. Laryngeal examina-
tion using rigid endoscopy revealed the presence of ulcers on
the laryngeal surface of the epiglottis and arytenoids
(Fig. 2a–c). BD was considered, and the patient was sent toed.
Figure 1 The endoscopic view of oropharynx examination.
Figure 3 The view of genital scatrisis.
Figure 4 The microscopic view of leukocytoclastic vasculitis
(200·, hemotoxylin-eosin stain).
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ation. The dermatological examination revealed the presence
of two genital scatris on scrotum and a pustular acneiform
rash on his thighs (Fig. 3). A pathergy test was negative at
48th hour examination, which had been applied to six different
points. Ophthalmological examination did not ﬁnd any oph-
thalmological pathologies. The results of the lingual biopsy
were consistent with leukocytoclastic vasculitis (Fig. 4).
Based on these ﬁndings, BD was diagnosed and the patient
was prescribed oral colchicine to be taken three times a day,
a topical corticosteroid, and an oral corticosteroid spray.
The severity of his symptoms decreased following treatment,
and he was symptom-free at his 1-year follow-up at a derma-
tology clinic.
2.1. Informed consent
Written informed consent was obtained from the patient who
participated in this case.
3. Discussion
VPI, in which the velopharyngeal port does not close during
speech, is an important condition that reduces the quality of
life in affected patients. The most common cause of VPI is
anatomical abnormalities,1 but we present the ﬁrst case of
VPI in a patient subsequently diagnosed with BD, a systemic
autoimmune vasculitis characterized by the presence of recur-
rent oral and genital ulcers, ocular inﬂammation, and skin
rashes.2,3 There are no speciﬁc laboratory tests conﬁrming a
diagnosis of BD; instead, diagnosis is contingent on the clinical
criteria published in 1990 by the International Study Group
for Behc¸et’s Disease (ISGBD) and a new scoring system pub-
lished at 2014. According to the conventional and new scoringFigure 2 (a–c) The endoscopicsystem our patients have 1 major plus 2 minor criteria and 5
points respectively.4
Patients with BD may have otorhinolaryngological symp-
toms as part of the multi-system disease involvement charac-
teristic of BD.2,3 Recurrent oral lesions are seen in 75–80%
of patients at the time of diagnosis and in essentially 100%
of patients during the course of the disease.2 However, the
presence of oral ulcers is not an absolute requirement for the
diagnosis of BD according to the new criteria proposed by
the International Team for the Revision of the International
Criteria for Behcet’s Disease.4view of larynx examination.
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petiform. Our patient had all three types, although the major
type was the most pronounced. The histopathological ﬁndings
of oral ulcers consist of leukocytoclastic vasculitis and are non-
speciﬁc,2 and such ﬁndings were seen in the lingual ulcer biopsy
from our patient. In contrast to the tongue lesions, pharyngo-
laryngeal manifestations occur rarely in BD.2,4 The BD litera-
ture describes pharyngolaryngeal stenosis, tracheoesophageal
ﬁstula, pharyngeal membranes, recurrent tonsillitis, and vocal
cord paralysis.2 The nearly nonexistent uvula in our patient
was probably the result of recurrent necrosis, since he had no
history of uvulopalatoplasty. Similarly, the highly ﬁbrotic right
palatine tonsil was also probably due to recurrent necrosis. The
severe pharyngolaryngeal manifestations and the mucosal
pathergy could be attributed to our patient’s history of orotra-
cheal intubation. However, the relationship between VPI and
the development of BD is unclear. VPI could be attributed to
the ﬁbrosis due to the mucosal pathergy in our patient.
BD can lead to sudden hearing loss, unilateral or bilateral
sensorineural hypoacusis, recurrent vertigo, and bilateral
Meniere syndrome affecting the cochlear nerve and the
vestibular system.5,6 Involvement of the nasal mucosa can lead
to dysosmia, nasal obstruction, and nasal ulcers.2,3 However,
our patient had no symptoms or signs of any of these
audiovestibular or nasal manifestations.
The treatment of BD depends on its severity but typically
includes glucocorticoids, colchicine, azathioprine, cyclospor-
ine, tacrolimus, and thalidomide.2,4 Topical corticosteroids,
oral spray, and gargles can also be used as needed. Our patient
was treated successfully with oral colchicine (3 · 1 per day) in
combination with a topical corticosteroid and an oral corticos-
teroid spray.
4. Conclusion
BD should be considered in the differential diagnosis of
patients with VPI. A high degree of clinical suspicion is neededto determine this rare potential etiology. Because patients with
BD can present with many different manifestations affecting
multiple systems, the otolaryngologist must be aware of BD
and its rare presentations.
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